Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Biotie Buys Newron In Pain Deal; Price Brings Little Relief

Sep 27 2011

• By The Pink Sheet Daily

Related Content

Biotie To Combine With Synosia To Form A "Global Leader" In CNS Drug Development

Jan 11 2011

UCB Provides Synosia With Its First Out-Licensing Deal And Leads Its $30M Series C Funding

Oct 12 2010

GSK Spins Out Pain Assets, Raises $35.4m

Oct 05 2010

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window